Health In Tech Partners with Ciklum to Enhance AI-Driven InsurTech Platform
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2026
0mins
Should l Buy HIT?
Source: Newsfilter
- Strategic Collaboration: Health In Tech has announced a strategic partnership with Ciklum, a global AI-powered software development firm, aimed at enhancing its AI-driven self-funded health insurance platform, which is expected to improve administrative, sales, and analytics capabilities, thereby increasing client service efficiency and expanding market share.
- Platform Functionality Expansion: This collaboration will integrate front- and back-end workflows, optimizing quoting, underwriting, administration, and analytics functions, which is anticipated to enhance user experience and platform adoption, ultimately driving market penetration across 40 states.
- Data Infrastructure Optimization: Ciklum will assist Health In Tech in streamlining data infrastructure and reporting processes through AWS-hosted solutions, providing deeper operational reporting capabilities to support decision-making for brokers, TPAs, MGUs, and employer clients.
- Long-Term Growth Potential: Tim Johnson, CEO of Health In Tech, stated that this partnership reflects the company's commitment to technology investments, aiming to enhance platform usability and customer retention, thus driving long-term revenue growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HIT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HIT
Wall Street analysts forecast HIT stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.420
Low
4.50
Averages
4.50
High
4.50
Current: 1.420
Low
4.50
Averages
4.50
High
4.50
About HIT
Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.
See More
HEALTH IN TECH REPORTS COMPLETION OF $7.0 MILLION PRIVATE PLACEMENT
- Announcement of Closure: Health Tech has announced the closure of a $7 million private placement.
- Impact on Funding: This closure may affect the company's financial strategies and future projects.
See More
HEALTH IN TECH INC ANTICIPATES APPROXIMATELY $7.0 MILLION IN GROSS PROCEEDS FROM PIPE, ACCORDING TO SEC FILING
Health in Tech: The health technology sector is experiencing significant financial activity, with gross proceeds from a recent PIPE expected to reach approximately $7 million.
PIPE Financing: The anticipated PIPE (Private Investment in Public Equity) filing indicates a strong interest in health tech investments, reflecting confidence in the sector's growth potential.
See More
HEALTH IN TECH INC ANNOUNCES PIPE AGREEMENT FOR 5.6 MILLION COMMON SHARES - SEC FILING
- Health Tech Company Agreement: A health technology company has entered into an agreement for the issuance of 5,600,000 common shares.
- SEC Filing: The agreement has been filed with the Securities and Exchange Commission (SEC).
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding to support the next phase of platform development.
- Support for Strategic Growth: CEO Tim Johnson stated that the additional capital will be allocated to key technology initiatives, enabling the company to launch new product capabilities actively requested by clients, thereby enhancing customer engagement and supporting sustainable revenue growth.
- Increased Market Visibility: CFO Julia Qian highlighted that the transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby strengthening its competitive position in the industry.
- Compliance Statement: The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered in the U.S., requiring investors to be aware of registration requirements and legal restrictions to ensure compliance.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech has successfully closed a private investment in public equity (PIPE) financing, raising approximately $7 million by issuing 5,600,000 shares at $1.25 each, which will provide essential funding for the company's technology development.
- Use of Proceeds: The company intends to allocate the net proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, thereby enhancing market competitiveness and addressing client demands to drive sustainable revenue growth.
- Investor Base Expansion: This transaction introduces new long-term institutional investors, which is expected to enhance the company's market visibility and support a broader capital markets strategy, thereby increasing financial flexibility.
- Strategic Development: CEO Tim Johnson stated that this financing will accelerate the next phase of platform development, further deepen customer engagement, and support the company's long-term growth strategy.
See More
Health In Tech Closes $7 Million PIPE Financing
- Financing Amount: Health In Tech successfully closed a PIPE financing of approximately $7 million, issuing 5,600,000 shares of common stock at $1.25 per share, which will provide essential funding for the company's platform development and enhance its competitive position in the market.
- Use of Proceeds: The company intends to allocate the proceeds towards expanding sales distribution, advancing technology development, and supporting new product initiatives, which will help deepen customer engagement and drive sustainable revenue growth.
- Investor Base Enhancement: This transaction introduces new long-term institutional investors to the shareholder base, which is expected to enhance market visibility and support the company's broader capital markets strategy while providing the flexibility to continue investing in technology and growth initiatives.
- Compliance Statement: The financing is conducted under Section 4(a)(2) of the Securities Act of 1933, and the securities have not been registered in the U.S., indicating that a resale registration statement may be required in the future to comply with securities laws.
See More
HEALTH IN TECH REPORTS COMPLETION OF $7.0 MILLION PRIVATE PLACEMENT
- Announcement of Closure: Health Tech has announced the closure of a $7 million private placement.
- Impact on Funding: This closure may affect the company's financial strategies and future projects.
See More
HEALTH IN TECH INC ANTICIPATES APPROXIMATELY $7.0 MILLION IN GROSS PROCEEDS FROM PIPE, ACCORDING TO SEC FILING
Health in Tech: The health technology sector is experiencing significant financial activity, with gross proceeds from a recent PIPE expected to reach approximately $7 million.
PIPE Financing: The anticipated PIPE (Private Investment in Public Equity) filing indicates a strong interest in health tech investments, reflecting confidence in the sector's growth potential.
See More
HEALTH IN TECH INC ANNOUNCES PIPE AGREEMENT FOR 5.6 MILLION COMMON SHARES - SEC FILING
- Health Tech Company Agreement: A health technology company has entered into an agreement for the issuance of 5,600,000 common shares.
- SEC Filing: The agreement has been filed with the Securities and Exchange Commission (SEC).
See More
